GlassScriptPhysician profile
Nathaniel David Weber
NPI 1891156063
$1,772.07
in general payments reported to CMS, 2019-2025
24 companies · $24.62 in 2025
The $24.62 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $313 · 2021: $309 · 2022: $725 · 2024: $104 · 2025: $24.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $128.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $229.91 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $172.39 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $165.78 | 2019-2022 | |
| Pfizer INC. | $137.19 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $136.79 | 2019-2022 | |
| Novo Nordisk INC | $132.91 | 2020-2022 | |
| Abbvie INC. | $119.83 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $83.84 | 2019-2022 | |
| Amgen INC. | $82.21 | 2020-2022 | |
| Davol INC. | $80.93 | 2024 | Arista Ah Flexitip |
| Amarin Pharma, INC. | $70.89 | 2019-2022 | |
| Glaxosmithkline, LLC. | $63.26 | 2019-2022 | |
| Kyowa Kirin, INC. | $56.09 | 2020-2022 | |
| Exact Sciences Corporation | $47.41 | 2024-2025 | Cologuard Collection Kit |
| Genentech USA, INC. | $38.12 | 2019-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $22.04 | 2020 | |
| Acadia Pharmaceuticals INC | $20.43 | 2021 | |
| Amneal Pharmaceuticals LLC | $20.41 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.07 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.27 | 2020 | |
| Dexcom, INC. | $15.27 | 2022 | |
| Astellas Pharma US INC | $15.07 | 2019 | |
| Shire North American Group INC | $12.79 | 2019 | |
| Mallinckrodt Enterprises LLC | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.